Ya-Lan Chang1,2, Pei-Wei Huang3, Chun-Ta Liao4,5, Hung-Ming Wang3, Chien-Yu Lin6,7, Shu-Ching Chen8,9,10. 1. Department of Nursing, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan. 2. School of Nursing, College of Medicine, Chang Gung University, Taoyuan, Taiwan. 3. Division of Medical Oncology, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan. 4. Department of Otorhinolaryngology, Head and Neck Surgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan. 5. Medicine of Department, College of Medicine, Chang Gung University, Taoyuan, Taiwan. 6. Department of Radiation Oncology and Proton and Radiation Therapy Center, Linkou Chang, Gung Memorial Hospital, Taoyuan, Taiwan. 7. Department of Medical Imaging and Radiological Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan. 8. Department of Radiation Oncology and Proton and Radiation Therapy Center, Linkou Chang, Gung Memorial Hospital, Taoyuan, Taiwan. shuching@gw.cgust.edu.tw. 9. School of Nursing and Geriatric and Long-Term Care Research Center, College of Nursing, Chang Gung University of Science and Technology, Taoyuan, Taiwan. shuching@gw.cgust.edu.tw. 10. School of Nursing, College of Medicine, Chang Gung University, Taoyuan, Taiwan. shuching@gw.cgust.edu.tw.
Abstract
PURPOSE: To identify factors associated with posttraumatic growth (PTG) of head-and-neck cancer squamous cancer (HNC) patients with oncologic emergencies (OE) within the first six months post-treatment. METHODS: We conducted a cross-sectional study of HNC patients in Taiwan from May 2019 to April 2021 using patient-reported outcomes. Patients were assessed for symptom distress, anxiety, fear of recurrence (FCR), and PTG. Multiple regression analysis was conducted to identify factors associated with PTG. The independent-samples t-test was used to compare PTG and its five specific domains in patients with low FCR, high FCR, low anxiety, and high anxiety. RESULTS: Of the 114 patients surveyed, 46.5% reported little-to-no PTG, and 53.5% had moderate-to-high PTG. Greater PTG was associated with greater FCR, longer time since OE, less anxiety, having a cancer recurrence, and greater educational attainment. These factors explained 38.6% of the variance in PTG. CONCLUSION: A notable proportion of HNC patients with OE-reported PTG but almost half-reported little-to-no PTG. PTG occurred most in the domain of appreciation of life. The study results also suggest that training patients in coping skills and inviting them to group growth experiences can help them increase PTG and cope with cancer-related psychological threats related to OE.
PURPOSE: To identify factors associated with posttraumatic growth (PTG) of head-and-neck cancer squamous cancer (HNC) patients with oncologic emergencies (OE) within the first six months post-treatment. METHODS: We conducted a cross-sectional study of HNC patients in Taiwan from May 2019 to April 2021 using patient-reported outcomes. Patients were assessed for symptom distress, anxiety, fear of recurrence (FCR), and PTG. Multiple regression analysis was conducted to identify factors associated with PTG. The independent-samples t-test was used to compare PTG and its five specific domains in patients with low FCR, high FCR, low anxiety, and high anxiety. RESULTS: Of the 114 patients surveyed, 46.5% reported little-to-no PTG, and 53.5% had moderate-to-high PTG. Greater PTG was associated with greater FCR, longer time since OE, less anxiety, having a cancer recurrence, and greater educational attainment. These factors explained 38.6% of the variance in PTG. CONCLUSION: A notable proportion of HNC patients with OE-reported PTG but almost half-reported little-to-no PTG. PTG occurred most in the domain of appreciation of life. The study results also suggest that training patients in coping skills and inviting them to group growth experiences can help them increase PTG and cope with cancer-related psychological threats related to OE.
Authors: A Eskander; M K Krzyzanowska; H D Fischer; N Liu; P C Austin; J C Irish; D J Enepekides; J Lee; E Gutierrez; E Lockhart; M Raphael; S Singh Journal: Oral Oncol Date: 2018-06-19 Impact factor: 5.337
Authors: Zachary R Moore; Nhat-Long Pham; Jennifer Lobo Shah; Lucien Nedzi; Baran D Sumer; Andrew T Day; Saad A Khan; David J Sher Journal: J Pain Symptom Manage Date: 2019-01-03 Impact factor: 3.612